Cargando…
Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
OBJECTIVES: In Japan, strong reimbursement pricing control measures for existing medical device products have rendered new medical device reimbursement pricing critical for manufacturers. Few studies have been conducted on this aspect; therefore, this paper (1) clarifies whether evaluation of innova...
Autores principales: | Tamura, Makoto, Nakano, Shohei, Sugahara, Takuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686657/ https://www.ncbi.nlm.nih.gov/pubmed/30549085 http://dx.doi.org/10.1002/hpm.2719 |
Ejemplares similares
-
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
por: Tsai, Hsin-Yi, et al.
Publicado: (2022) -
Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023) -
Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
por: Kusaoi, Makio, et al.
Publicado: (2020) -
Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983) -
Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)